IL126476A0 - Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents - Google Patents

Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents

Info

Publication number
IL126476A0
IL126476A0 IL12647697A IL12647697A IL126476A0 IL 126476 A0 IL126476 A0 IL 126476A0 IL 12647697 A IL12647697 A IL 12647697A IL 12647697 A IL12647697 A IL 12647697A IL 126476 A0 IL126476 A0 IL 126476A0
Authority
IL
Israel
Prior art keywords
aminothienopyridine
aminoisoquinolines
derivatives
inflammatory agents
inflammatory
Prior art date
Application number
IL12647697A
Other languages
English (en)
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9607717.7A external-priority patent/GB9607717D0/en
Priority claimed from GBGB9608678.0A external-priority patent/GB9608678D0/en
Priority claimed from GBGB9610892.3A external-priority patent/GB9610892D0/en
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of IL126476A0 publication Critical patent/IL126476A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL12647697A 1996-04-13 1997-04-09 Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents IL126476A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9607717.7A GB9607717D0 (en) 1996-04-13 1996-04-13 Pharmaceutically active comounds
GBGB9608678.0A GB9608678D0 (en) 1996-04-26 1996-04-26 Pharmaceuticlly active compounds
GBGB9610892.3A GB9610892D0 (en) 1996-05-24 1996-05-24 Pharmaceutically active compounds
PCT/SE1997/000589 WO1997038977A1 (en) 1996-04-13 1997-04-09 Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents

Publications (1)

Publication Number Publication Date
IL126476A0 true IL126476A0 (en) 1999-08-17

Family

ID=27268241

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12647697A IL126476A0 (en) 1996-04-13 1997-04-09 Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents

Country Status (21)

Country Link
US (1) US6063789A (hu)
EP (1) EP0892784A1 (hu)
JP (1) JP2000509028A (hu)
KR (1) KR20000005388A (hu)
CN (1) CN1221407A (hu)
AR (1) AR006619A1 (hu)
AU (1) AU706110B2 (hu)
BR (1) BR9708607A (hu)
CA (1) CA2251681A1 (hu)
CZ (1) CZ327698A3 (hu)
EE (1) EE9800339A (hu)
HU (1) HUP9901739A3 (hu)
ID (1) ID16575A (hu)
IL (1) IL126476A0 (hu)
IS (1) IS4862A (hu)
NO (1) NO984761L (hu)
NZ (1) NZ331932A (hu)
PL (1) PL329308A1 (hu)
SK (1) SK134698A3 (hu)
TR (1) TR199802060T2 (hu)
WO (1) WO1997038977A1 (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1009758B1 (en) 1997-08-29 2005-06-01 Tularik Limited Meta-benzamidine derivatives as serine protease inhibitors
AU9298098A (en) * 1997-09-03 1999-03-22 Guilford Pharmaceuticals Inc. Amino-substituted compounds, methods, and compositions for inhibiting parp activity
DK1100789T3 (da) 1998-07-24 2005-05-23 Bayer Cropscience Ag Substituerede benzoylcyclohexandioner
IT1302677B1 (it) * 1998-10-15 2000-09-29 Zambon Spa Derivati benzazinici inibitori della fosfodiesterasi 4
TW575567B (en) 1998-10-23 2004-02-11 Akzo Nobel Nv Serine protease inhibitor
SE9901530D0 (sv) * 1999-04-28 1999-04-28 Astra Pharma Prod Novel compounds
DE19920791A1 (de) 1999-05-06 2000-11-09 Bayer Ag Substituierte Benzoylisoxazole
DE19921424A1 (de) 1999-05-08 2000-11-09 Bayer Ag Substituierte Benzoylketone
DE19946853A1 (de) 1999-09-30 2001-04-05 Bayer Ag Substituierte Arylketone
TW591031B (en) * 2000-02-29 2004-06-11 Takeda Chemical Industries Ltd Thienopyridine derivatives, their production and use
US7012098B2 (en) * 2001-03-23 2006-03-14 Pharmacia Corporation Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
EP2597087B1 (en) 2005-10-25 2016-03-30 Shionogi&Co., Ltd. Dihydrooxazine and tetrahydropyrimidine derivatives as BACE 1 inhibitors
TW200804290A (en) * 2005-11-15 2008-01-16 Astrazeneca Ab Compounds and uses thereof
US8653067B2 (en) 2007-04-24 2014-02-18 Shionogi & Co., Ltd. Pharmaceutical composition for treating Alzheimer's disease
CA2683887A1 (en) 2007-04-24 2008-11-06 Shionogi & Co., Ltd. Aminodihydrothiazine derivatives substituted with a cyclic group having inhibitory activity against production of amyloid beta protein
AU2009258496B8 (en) 2008-06-13 2014-06-26 Shionogi & Co., Ltd. Sulfur-containing heterocyclic derivative having beta-secretase-inhibiting activity
WO2010047372A1 (ja) 2008-10-22 2010-04-29 塩野義製薬株式会社 Bace1阻害活性を有する2-アミノピリミジン-4-オンおよび2-アミノピリジン誘導体
BR112012013854A2 (pt) 2009-12-11 2019-09-24 Shionogi & Co derivados de oxazina.
CN101863900B (zh) * 2010-06-29 2012-07-25 天津药物研究院 一氧化氮供体型噻吩并吡啶衍生物、其制备方法和用途
JP5766198B2 (ja) 2010-10-29 2015-08-19 塩野義製薬株式会社 縮合アミノジヒドロピリミジン誘導体
EP2634186A4 (en) 2010-10-29 2014-03-26 Shionogi & Co naphthyridine
WO2012147763A1 (ja) 2011-04-26 2012-11-01 塩野義製薬株式会社 オキサジン誘導体およびそれを含有するbace1阻害剤
JP2016501827A (ja) 2012-10-24 2016-01-21 塩野義製薬株式会社 Bace1阻害作用を有するジヒドロオキサジンまたはオキサゼピン誘導体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663550A (en) * 1968-12-25 1972-05-16 Shionogi & Co 2-lower alkyl-2,3-dihydrothieno(3,2-c)quinoline oxides
US3903095A (en) * 1972-02-18 1975-09-02 Merck & Co Inc Certain substituted-thieno{8 3,2-c{9 -pyridines
GB1379111A (en) * 1972-04-13 1975-01-02 Aspro Nicholas Ltd Preparation of fused-ring pyridine and pyrazine derivatives
US4127720A (en) * 1977-09-21 1978-11-28 Bristol-Myers Company Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity
JPH04348326A (ja) * 1990-07-09 1992-12-03 Sumitomo Electric Ind Ltd 有機非線形光学材料
EP0724570B1 (en) * 1993-10-21 1999-03-03 G.D. Searle & Co. Amidino derivatives useful as nitric oxide synthase inhibitors

Also Published As

Publication number Publication date
EP0892784A1 (en) 1999-01-27
IS4862A (is) 1998-10-07
SK134698A3 (en) 1999-06-11
AU706110B2 (en) 1999-06-10
AR006619A1 (es) 1999-09-08
EE9800339A (et) 1999-04-15
KR20000005388A (ko) 2000-01-25
HUP9901739A3 (en) 2000-06-28
US6063789A (en) 2000-05-16
ID16575A (id) 1997-10-16
TR199802060T2 (xx) 1999-01-18
CN1221407A (zh) 1999-06-30
HUP9901739A2 (hu) 1999-09-28
PL329308A1 (en) 1999-03-15
BR9708607A (pt) 1999-08-03
AU2655097A (en) 1997-11-07
NO984761L (no) 1998-12-14
JP2000509028A (ja) 2000-07-18
CZ327698A3 (cs) 1999-05-12
WO1997038977A1 (en) 1997-10-23
NO984761D0 (no) 1998-10-12
NZ331932A (en) 2000-02-28
CA2251681A1 (en) 1997-10-23

Similar Documents

Publication Publication Date Title
HUP0000369A3 (en) 3-thiocarbamoylpyrazole derivatives and their use as pesticides
IL126476A0 (en) Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
GB9701206D0 (en) Serine derivatives and their use as therapeutic agents
AU3577995A (en) Urea derivatives and their use as acat-inhibitors
HRP970680B1 (en) New ketobenzamides and their use
IL128800A0 (en) 4-Heteroylpyrazol derivatives and the use thereof as herbicides
AU2766097A (en) Acyl mercapto-triazolyl derivatives and the use thereof as microbicides
HUP0101172A3 (en) Ortho-anthranilamide derivatives and their use as anti-coagulants
AU3352097A (en) Substituted piperazinyl-phenyl-oxazolidinone derivatives and their use as anti-bacterial agents
AU1315797A (en) Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents
IL126900A0 (en) Spiro-piperidine derivatives and their use as therapeutic agents
EP1024130A4 (en) BIPHENYL-5-ALKANIC ACID DERIVATIVES AND THEIR USE
AU2952997A (en) Thiocyano-triazolyl derivatives and their use as microbicides
IL115891A0 (en) Hemorrhoidial compositions and their use
ZA975591B (en) New amidino derivatives and their use as thrombininhibitors
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
IL114795A0 (en) N-benzylindole- and benmzopyrazole derivatives their preparation and use
SG91796A1 (en) N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use
AU2896597A (en) Sulphonyl-mercapto-triazolyl derivatives and their use as microbicides
HRP970225A2 (en) Benzofuryl derivatives and their use
IL129089A0 (en) New derivatives from piperidine-keto acid their preparation and use
ZA973097B (en) Novel aspire-hydroxy acid derivatives their preparation and use
ZA978876B (en) Oxazolone derivatives and their use
HUP0001781A3 (en) Substituted pyrazolyl-pyrazole derivatives and their use as herbicides
AU3268197A (en) Spiro-piperidine derivatives and their use as therapeutic agents